Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Mar;35(3):506–511. doi: 10.1128/aac.35.3.506

Effect of SDZ MRL 953 on the survival of mice with advanced sepsis that cannot be cured by antibiotics alone.

C Lam 1, E Schütze 1, E Liehl 1, P Stütz 1
PMCID: PMC245040  PMID: 2039201

Abstract

Stimulation of nonspecific immunity as an additional modality for therapy of sepsis that cannot be cured by antibiotics alone was investigated. SDZ MRL 953, a novel monosaccharidic lipid A analog as a prototype immunostimulant, and cefotaxime or gentamicin were administered to normal or myelosuppressed mice in a state of advanced sepsis caused by Escherichia coli or Staphylococcus aureus. In this novel model, antibiotic therapy was initiated when the infected mice appeared moribund. At this stage, neither pretreatment with the immunostimulant nor therapy with high doses of cefotaxime or gentamicin was effective in protecting the animals from fatal sepsis. However, pretreatment with a single dose of SDZ MRL 953 1 day prior to microbial inoculation dramatically improved the curative effects of the antibiotics. Hence, long-term survival was significantly enhanced with increasing doses of the immunostimulant in the combined therapy. Peritoneal macrophages from SDZ MRL 953-pretreated animals were primed for enhanced production of microbicidal reactive oxygen metabolites in vitro. In conclusion, the results of the present study indicate that SDZ MRL 953 is a potential candidate for use in a clinical setting as an adjunct to antimicrobial therapy for infections that cannot be treated successfully with appropriate antibiotics alone.

Full text

PDF
506

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chase J. J., Kubey W., Dulek M. H., Holmes C. J., Salit M. G., Pearson F. C., 3rd, Ribi E. Effect of monophosphoryl lipid A on host resistance to bacterial infection. Infect Immun. 1986 Sep;53(3):711–712. doi: 10.1128/iai.53.3.711-712.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cross A. S., Sadoff J. C., Kelly N., Bernton E., Gemski P. Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection. J Exp Med. 1989 Jun 1;169(6):2021–2027. doi: 10.1084/jem.169.6.2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Deitch E. A. Infection in the compromised host. Surg Clin North Am. 1988 Feb;68(1):181–197. doi: 10.1016/s0039-6109(16)44439-7. [DOI] [PubMed] [Google Scholar]
  4. Ikeda S., Nishimura C., Nakatsuka M., Homma J. Y., Kiso M., Hasegawa A. Antiviral and immunomodulating activities of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-60. Antiviral Res. 1988 Jan-Feb;9(1-2):37–46. doi: 10.1016/0166-3542(88)90065-4. [DOI] [PubMed] [Google Scholar]
  5. Ikeda S., Tominaga T., Nishimura C., Homma J. Y., Kiso M., Hasegawa A. Antiherpes activity of chemically synthesized lipid A-subunit analogue GLA-60 in immunosuppressed mice. Antiviral Res. 1989 May-Jun;11(4):173–180. doi: 10.1016/0166-3542(89)90002-8. [DOI] [PubMed] [Google Scholar]
  6. Johnston R. B., Jr, Godzik C. A., Cohn Z. A. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med. 1978 Jul 1;148(1):115–127. doi: 10.1084/jem.148.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kurtz R. S., Young K. M., Czuprynski C. J. Separate and combined effects of recombinant interleukin-1 alpha and gamma interferon on antibacterial resistance. Infect Immun. 1989 Feb;57(2):553–558. doi: 10.1128/iai.57.2.553-558.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lam C., Schütze E., Hildebrandt J., Aschauer H., Liehl E., Macher I., Stütz P. SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis. Antimicrob Agents Chemother. 1991 Mar;35(3):500–505. doi: 10.1128/aac.35.3.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Madonna G. S., Ledney G. D., Elliott T. B., Brook I., Ulrich J. T., Myers K. R., Patchen M. L., Walker R. I. Trehalose dimycolate enhances resistance to infection in neutropenic animals. Infect Immun. 1989 Aug;57(8):2495–2501. doi: 10.1128/iai.57.8.2495-2501.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McCabe W. R. Antibiotics and endotoxic shock. Bull N Y Acad Med. 1975 Oct;51(9):1084–1095. [PMC free article] [PubMed] [Google Scholar]
  11. Ozaki Y., Ohashi T., Minami A., Nakamura S. Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a. Infect Immun. 1987 Jun;55(6):1436–1440. doi: 10.1128/iai.55.6.1436-1440.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Periti P., Mazzei T. Infections in immunocompromised patients. II. Established therapy and its limitations. Clin Ther. 1985;8(1):100–117. [PubMed] [Google Scholar]
  13. Polk H. C., Jr, Galland R. B., Ausobsky J. R. Nonspecific enhancement of resistance to bacterial infection: evidence of an effect supplemental to antibiotics. Ann Surg. 1982 Oct;196(4):436–441. doi: 10.1097/00000658-198210000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Urbaschek R., Urbaschek B. Induction of nonspecific resistance and stimulation of granulopoiesis by endotoxins and nontoxic bacterial cell wall components and their passive transfer. Ann N Y Acad Sci. 1985;459:97–110. doi: 10.1111/j.1749-6632.1985.tb20819.x. [DOI] [PubMed] [Google Scholar]
  15. Wymann M. P., von Tscharner V., Deranleau D. A., Baggiolini M. Chemiluminescence detection of H2O2 produced by human neutrophils during the respiratory burst. Anal Biochem. 1987 Sep;165(2):371–378. doi: 10.1016/0003-2697(87)90284-3. [DOI] [PubMed] [Google Scholar]
  16. van der Meer J. W., Barza M., Wolff S. M., Dinarello C. A. A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1620–1623. doi: 10.1073/pnas.85.5.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES